There is no better tap than Altimmune Inc (ALT) Stock
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
Is Altimmune Inc (ALT) Stock A Better Investment Than Its Rivals?
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
With upside potential, Altimmune Inc (ALT) Stock is well-positioned to grow
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
Altimmune Inc (NASDAQ:ALT) Stock is trading Higher 83.59% From 200-Day SMA
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
Does A Technical Metric Suggest That Altimmune Inc (ALT) Stock Is Ready To Rise?
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
Altimmune Inc (ALT) Stock: Amazing technical data that you never knew existed
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
Why Altimmune Inc (NASDAQ:ALT) Stock climbed 29.71% in Last Three Months?
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
Altimmune Inc (ALT) Stock is Just Right Size-Neither Too Big Nor Too Small
Goldman raised the price target for the Altimmune Inc (NASDAQ:ALT) stock to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on March 22, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target of $6 […]
